Meloxicam Cyclodextrin Complex with Bicarbonate for Faster Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Meloxicam, a nonsteroidal anti-inflammatory drug, has poor aqueous solubility which limits its bioavailability and slows the onset of pain relief, necessitating improved formulations to enhance its absorption and efficacy.
Innovation Solution
A combination of meloxicam with sulfobutyl ether β-cyclodextrin (SBEβCD) and a bicarbonate, such as sodium bicarbonate, forms an inclusion complex to increase solubility and bioavailability, allowing for rapid and sustained pain relief when administered with rizatriptan for treating conditions like migraine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If meloxicam is used as a conventional NSAID formulation, then it provides anti-inflammatory and analgesic effects, but its poor aqueous solubility reduces bioavailability and slows the onset of pain relief
Solution Approach 1:
The patent uses cyclodextrins as intermediary carriers that form inclusion complexes with meloxicam. The cyclodextrin structure with its hydrophobic interior and hydrophilic exterior acts as a mediator, encapsulating the poorly soluble meloxicam molecule and enabling its transport in aqueous environments, thereby improving bioavailability and accelerating onset of action
Solution Approach 2:
The patent modifies the physical-chemical parameters of meloxicam by forming inclusion complexes with cyclodextrins. This changes the solubility parameter of meloxicam from poor to improved, and alters the release kinetics to achieve faster onset of pain relief while maintaining the drug's therapeutic effects
2Reliability
If the dosage form includes multiple components (meloxicam complex, bicarbonate, rizatriptan), then treatment efficacy for migraine is enhanced, but the device complexity increases
Solution Approach 1:
The patent combines multiple therapeutic agents (meloxicam complex, bicarbonate, and rizatriptan) into a single integrated dosage form. This merging approach ensures synchronized delivery of all components, improving treatment reliability for migraine while maintaining ease of administration through a unified formulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination significantly enhances the bioavailability and absorption of meloxicam, providing rapid and sustained relief from migraine symptoms, reducing the need for rescue medication and improving treatment outcomes in patients with a history of inadequate responses to prior treatments.
Implementation Method 1
In aqueous solutions, cyclodextrins can form complexes (i.e., an inclusion complex) with drugs by incorporating the drug into the center/hydrophobic portion of the cyclodextrin ring
Implementation Method 2
Disclosed herein are formulations for an inclusion complex of cyclodextrin and meloxicam with bicarbonate and methods of use thereof
Data Source
AI summary
Disclosed herein are compositions comprising an NSAID such as meloxicam and/or rizatriptan in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the NSAID for the treatment of pain such as migraine, arthritis, and other conditions. Also disclosed herein are methods of treating pain, such as migraine, comprising administering meloxicam and rizatriptan to a human being suffering from pain, such as migraine. For migraine, these methods may be particularly useful when the meloxicam and rizatriptan are administered while the human being is suffering from an acute attack of migraine pain or migraine aura. In some embodiments, the combination of meloxicam and rizatriptan may be administered in a manner that results in a Tmax of meloxicam of 3 hours or less.